Raymond James analyst Patrick O’Shaughnessy lowered the firm’s price target on CME Group (CME) to $307 from $309 and keeps an Outperform rating on the shares ahead of the Q3 earnings report. CME’s suite of risk management tools positions the firm well in a volatile global macroeconomic and geopolitical backdrop, though when volatility subsides as it did during the past few months, CME’s futures volumes can moderate and lead to near-term downside estimate revisions, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group price target lowered to $280 from $298 at Barclays
- Crypto Currents: Bitcoin Depot acquires National Bitcoin ATM assets
- CME Group to offer around-the-clock trading for crypto futures, options
- CME Group price target lowered to $204 from $212 at BofA
- CME Group reports September ADV of 26.1M contracts